Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Launched by NATIONAL CANCER INSTITUTE (NCI) · Sep 21, 2013

Keywords

ClinConnect Summary

This clinical trial is focused on studying patients with malignant mesothelioma, a type of cancer that affects the lining of the lungs and other organs. The goal of the study is to collect samples from patients to help researchers learn more about this disease and its treatment options. It aims to enroll up to 1,000 participants, including anyone aged 2 years and older who has been diagnosed with malignant mesothelioma, as well as those with certain other cancer types. If you're over 18, you will need to provide consent to participate; if you're under 18, a parent or guardian will need to give their consent.

Participants in the trial can expect to provide samples of blood, urine, and tumor tissue, which will be stored for future research. The study will also follow participants over time to monitor their disease and any treatments they receive. This research is important because it aims to improve our understanding of mesothelioma and may lead to better treatment options in the future. If you or a loved one has malignant mesothelioma, this trial might be a valuable opportunity to contribute to important cancer research.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • All participants greater than or equal to 2 years of age with malignant mesothelioma.
• • All participants greater than or equal to18 years of age with thymic carcinoma, pancreatic or biliary adenocarcinoma or lung, gastric or ovarian cancers.
• • Confirmed pathological diagnosis is required
• • Ability and willingness of participant to provide informed consent to participation.
• EXCLUSION CRITERIA:
• • Active symptomatic major organ disorder that would increase the risk of biopsy, including but not limited to ischemic heart disease, recent myocardial infarction, active congestive heart failure, pulmonary dysfunction.
• • Pregnant women
• • Active concomitant medical or psychological illnesses that may increase the risk to the participant or in adult participants, inability to obtain informed consent, at the discretion of the principal investigator.